Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Angler101on Oct 03, 2023 6:47pm
139 Views
Post# 35667981

RE:RE:RE:RE:RE:Buy-out potential???

RE:RE:RE:RE:RE:Buy-out potential???I get what you’re saying fox, but one thing you’re not seeing is that we’re so ridiculously undervalued right now, and there’s a good reason for that. Think about it....does it make sense that a biotech that just had the trial results we’ve had, and just easily raised 15 mil and then another 2.5 mil., and was just honoured with an amazing platform at ASCO, and then was just taken on by PanCan to pay for a good part of the phase 3 trial, and then awarded another 5 mil for another trial by PanCan, amongst many other positive indications.....does it make any sense to you that we’ve seen a decline in sp, and there’s a 60% short position?......it seems pretty obvious to me that the sp is being manipulated and whoever is manipulating is accumulating shares.....I’ve seen it happen countless times before, and it’s how the stock market works.
<< Previous
Bullboard Posts
Next >>